2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: The Task Force for diabetes, pre-diabetes …

F Cosentino, PJ Grant, V Aboyans… - European heart …, 2020 - academic.oup.com
Health professionals are encouraged to take the Guidelines fully into account when
exercising their clinical judgment, as well as in the determination and the implementation of …

2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk The Task Force for the management of …

F Mach, C Baigent, AL Catapano… - European heart …, 2020 - academic.oup.com
version of the Guidelines, which is freely available via the ESC and EAS websites and
hosted on their journals' websites (EHJ and Atherosclerosis Journal). The National Cardiac …

[HTML][HTML] Machine learning and data mining methods in diabetes research

I Kavakiotis, O Tsave, A Salifoglou… - Computational and …, 2017 - Elsevier
The remarkable advances in biotechnology and health sciences have led to a significant
production of data, such as high throughput genetic data and clinical information, generated …

[PDF][PDF] 2016 European Guidelines on cardiovascular disease prevention in clinical practice

MF Piepoli, AW Hoes, S Agewall… - Polish Heart …, 2016 - journals.viamedica.pl
2.3. 9. Wnioski................................................ 838 2.4. Inne markery ryzyka.......................................
. 840 2.4. 1. Wywiad rodzinny/(epi) genetyka............ 840 2.4. 1.1. Wywiad …

[PDF][PDF] 2016 ESC/EAS guidelines for the management of dyslipidaemias

AL Catapano, I Graham, G De Backer… - Polish Heart …, 2016 - journals.viamedica.pl
5.1. Wpływ stylu życia na stężenie cholesterolu całkowitego i stężenie cholesterolu frakcji
lipoprotein o małej gęstości................................ 1259 5.2. Wpływ stylu życia na stężenie …

Macrovascular complications of type 2 diabetes mellitus

M Viigimaa, A Sachinidis… - Current vascular …, 2020 - ingentaconnect.com
Background: Type 2 diabetes mellitus (T2DM) has emerged as a pandemic. It has different
complications, both microvascular and macrovascular. Objective: The purpose of this review …

[HTML][HTML] ISPAD Clinical Practice Consensus Guidelines 2018: Microvascular and macrovascular complications in children and adolescents

KC Donaghue, ML Marcovecchio, RP Wadwa… - Pediatric …, 2018 - ncbi.nlm.nih.gov
The long-term vascular complications of diabetes include nephropathy, retinopathy,
neuropathy, and macrovascular disease. The outcomes are:• renal failure and hypertension …

Glycemic control and excess mortality in type 1 diabetes

M Lind, AM Svensson, M Kosiborod… - … England Journal of …, 2014 - Mass Medical Soc
Background The excess risk of death from any cause and of death from cardiovascular
causes is unknown among patients with type 1 diabetes and various levels of glycemic …

Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart Association and American Diabetes Association

SD De Ferranti, IH De Boer, V Fonseca, CS Fox… - Circulation, 2014 - Am Heart Assoc
(CVD) in individuals with type 1 diabetes mellitus (T1DM), the pathophysiology underlying
the relationship between cardiovascular events, CVD risk factors, and T1DM is not well …

Mechanisms of diabetic complications

JM Forbes, ME Cooper - Physiological reviews, 2013 - journals.physiology.org
It is increasingly apparent that not only is a cure for the current worldwide diabetes epidemic
required, but also for its major complications, affecting both small and large blood vessels …